Healthcare provider profile · identity verified

Todd E Helton, M.D., PHD.

Internal Medicine · RALEIGH, NC · NPI 1194701425

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	299	63
Atorvastatin Calcium	Atorvastatin Calcium	283	64
Eliquis	Apixaban	197	29
Amlodipine Besylate	Amlodipine Besylate	183	44
Losartan Potassium	Losartan Potassium	178	46
Rosuvastatin Calcium	Rosuvastatin Calcium	143	31
Metoprolol Succinate	Metoprolol Succinate	134	29
Gabapentin	Gabapentin	110	21
Synthroid	Levothyroxine Sodium	106	18
Trazodone Hcl	Trazodone Hcl	104	28
Furosemide	Furosemide	103	21
Omeprazole	Omeprazole	102	21
Escitalopram Oxalate	Escitalopram Oxalate	98	17
Pantoprazole Sodium	Pantoprazole Sodium	97	25
Potassium Chloride	Potassium Chloride	97	19
Metoprolol Tartrate	Metoprolol Tartrate	82	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	78	19
Sertraline Hcl	Sertraline Hcl	74	19
Pravastatin Sodium	Pravastatin Sodium	72	20
Metformin Hcl Er	Metformin Hcl	71	12
Alprazolam	Alprazolam	69	19
Lisinopril	Lisinopril	68	13
Tramadol Hcl	Tramadol Hcl	63	14
Allopurinol	Allopurinol	62	16
Ezetimibe	Ezetimibe	59	13
Simvastatin	Simvastatin	56	15
Irbesartan	Irbesartan	53	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	53	15
Prednisone	Prednisone	51	15
Zolpidem Tartrate	Zolpidem Tartrate	51	suppressed
Duloxetine Hcl	Duloxetine Hcl	50	suppressed
Metformin Hcl	Metformin Hcl	49	14
Cefuroxime	Cefuroxime Axetil	48	40
Doxycycline Hyclate	Doxycycline Hyclate	47	32
Finasteride	Finasteride	45	suppressed
Buspirone Hcl	Buspirone Hcl	44	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	44	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	44	suppressed
Ibandronate Sodium	Ibandronate Sodium	43	14
Tamsulosin Hcl	Tamsulosin Hcl	43	11
Xarelto	Rivaroxaban	43	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	39	suppressed
Lorazepam	Lorazepam	38	13
Donepezil Hcl	Donepezil Hcl	36	suppressed
Linzess	Linaclotide	36	suppressed
Rybelsus	Semaglutide	36	suppressed
Hydralazine Hcl	Hydralazine Hcl	35	suppressed
Ozempic	Semaglutide	35	suppressed
Bupropion Hcl Sr	Bupropion Hcl	34	suppressed
Carvedilol	Carvedilol	32	suppressed
Clonazepam	Clonazepam	32	suppressed
Glimepiride	Glimepiride	32	suppressed
Azithromycin	Azithromycin	31	22
Celecoxib	Celecoxib	31	suppressed
Mirtazapine	Mirtazapine	31	suppressed
Pregabalin	Pregabalin	30	11
Hydrochlorothiazide	Hydrochlorothiazide	29	suppressed
Meloxicam	Meloxicam	29	12
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	29	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	28	suppressed
Rivastigmine	Rivastigmine Tartrate	28	suppressed
Telmisartan	Telmisartan	28	suppressed
Warfarin Sodium	Warfarin Sodium	28	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	27	11
Clopidogrel	Clopidogrel Bisulfate	26	suppressed
Doxepin Hcl	Doxepin Hcl	26	suppressed
Spironolactone	Spironolactone	26	suppressed
Nitroglycerin	Nitroglycerin	25	suppressed
Atenolol	Atenolol	24	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Methylprednisolone	Methylprednisolone	24	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	24	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	24	21
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	15
Benazepril Hcl	Benazepril Hcl	23	suppressed
Diazepam	Diazepam	23	suppressed
Febuxostat	Febuxostat	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	22	suppressed
Montelukast Sodium	Montelukast Sodium	22	suppressed
Cefdinir	Cefdinir	21	19
Januvia	Sitagliptin Phosphate	21	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Valsartan	Valsartan	21	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	suppressed
Baclofen	Baclofen	18	suppressed
Cephalexin	Cephalexin	18	14
Estradiol	Estradiol	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Torsemide	Torsemide	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Midodrine Hcl	Midodrine Hcl	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Mounjaro	Tirzepatide	16	suppressed
Nystatin	Nystatin	15	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	14	suppressed
Methocarbamol	Methocarbamol	14	11
Promethazine Hcl	Promethazine Hcl	14	suppressed
Rocklatan	Netarsudil Mesylat/Latanoprost	14	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	14	suppressed
Fluticasone Propionate	Fluticasone Propionate	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Ramipril	Ramipril	13	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Colchicine	Colchicine	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Trintellix	Vortioxetine Hydrobromide	12	suppressed
Zaleplon	Zaleplon	12	suppressed
Bumetanide	Bumetanide	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Famotidine	Famotidine	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	11	suppressed
Risperidone Odt	Risperidone	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error